Charge‐transfer complexes of 4‐(di­methyl­amino)­pyridine with 2,4‐, 3,4‐ and 3,5‐di­nitro­benzoic acid

In the three title crystal structures 4‐(di­methyl­amino)­pyridinium 2,4‐di­nitro­benzoate, (I), 4‐(di­methyl­amino)­pyri­dinium 3,4‐di­nitro­benzo­ate, (II), and 4‐(di­methyl­amino)pyri­din­ium 3,5‐di­nitro­benzo­ate, (III), all C₇H₁₁N₂⁺·C₇H₃N₂O₆^?, the ions are connected by an N—H?O hydrogen bond. Dihedral angles between the pyridine and phenyl rings are 69.9 (1), 26.7 (1) and 56.2 (1)° in (I), (II) and (III), respectively. Donor–acceptor π–π stacking is observed in (II) and (III), but not in (I).     

2‐Amino derivatives of 5‐nitro­phenyl­acet­amide

The structures of the potential non‐linear optical (NLO) materials N‐[2‐(iso­propyl­amino)‐5‐nitro­phenyl]­acet­amide, (I) C₁₁H₁₅N₃O₃, and N‐[2‐(butyl­amino)‐5‐nitro­phenyl]­acet­amide, (II) C₁₂H₁₇N₃O₃, have been investigated by X‐ray analysis. To compare them with the structure of N‐[2‐(di­methyl­amino)‐5‐nitro­phenyl]­acet­amide, (III) C₁₀H₁₃N₃O₃, a known NLO compound, we had to redetermine the structure of (III), since it was described only briefly in the literature. There are two mol­ecules in the asymmetric unit of compound (I), which have different orientations of the substituents with respect to the benzene ring. The packing of mol­ecules in (II) and (III) contains stacks but both (I) and (II) crystallize in a centrosymmetric space group, which renders them inappropriate for NLO applications.     

cis‐[1,4‐Bis(di­phenyl­phosphino)­butane](μ‐tetra­thio­tungstato)­palladium(II) N,N′‐di­methyl­form­amide hemisolvate hemihydrate

In the title compound, [1,4‐bis(di­phenyl­phosphino)­butane‐2κ²P,P′]­di‐μ‐thio‐1:2κ⁴S‐di­thio‐1κ²S‐palladium(II)­tung­sten(VI) N,N′‐di­methyl­form­amide hemisolvate hemihydrate, [PdWS₄­(C₂₈H₂₈P₂)]·0.5C₃H₇NO·0.5H₂O, the Pd atom is coordinated by two S atoms from the distorted‐tetrahedral [WS₄]²⁻ anion and two P atoms from the dppb mol­ecule [dppb is 1,4‐bis(di­phenyl­phos­phino)­butane] in an approximately square‐planar configuration. A puckered seven‐membered ring is formed by the Pd atom and the dppb ligand.     

cis,cis‐Ceratospong­amide N,N‐di­methyl­acet­amide hemisolvate in the presence of twinning

Ceratospong­amide (CS) is a potent inhibitor of secreted phospho­lipase A₂, and cis,cis and trans,trans isomers, related with respect to the two proline amide bonds, are known. Crystals of cis,cis‐CS were grown from N,N‐di­methyl­acet­amide solution, giving the title compound, the cyclic ester of isoleucyl­oxazolinyl­phenyl­alanyl­prolyl­thia­zolyl­phenyl­alanyl­pro­line [cyclo(‐Ile–Oxz–Phe–Pro–Thz–Phe–Pro‐)] N,N‐di­methyl­acet­amide hemisolvate, C₄₁H₄₉N₇O₆S·0.5C₄H₉NO. The structure is the third example of cis,cis‐CS to be investigated and comprises twinned crystals, in which the a and b axes are interchanged. The ratio of co‐existing twin crystals is approximately 50%. The peptide has a `saddle‐like' structure and is very similar to previously reported structures of cis,cis‐CS, which implies that the structure of cis,cis‐CS is very stable in spite of differences in crystallization conditions.     

Bis(2,5‐dimethoxy‐4‐methylphenyl)methane and bis(2,5‐dimethoxy‐3,4,6‐trimethylphenyl)methane

Bis(2,5‐di­methoxy‐4‐methyl­phenyl)­methane, C₁₉H₂₄O₄, (IIa), was obtained and characterized as a minor product from the reaction of tolu­hydro­quinone di­methyl ether (1,4‐dimethoxy‐2‐methylbenzene) with N‐(hydroxy­methyl)­tri­fluoro­acet­amide. Similarly, bis(2,5‐di­methoxy‐3,4,6‐tri­methyl­phenyl)­methane, C₂₃H₃₂O₄, (IIb), was prepared from the corresponding reaction of tri­methyl­hydro­quinone di­methyl ether (2,5‐dimethoxy‐1,3,4‐trimethylbenzene). The mol­ecules of (IIa) and (IIb) each lie on a twofold axis passing through the methyl­ene group. The dihedral angle between the planar phenyl rings is 73.4 (1)° in (IIa) and 77.9 (1)° in (IIb). The external bond angles around the bridging methyl­ene group are 116.6 (2) and 117.3 (2)° for (IIa) and (IIb), respectively. In (IIa), the methoxy substituents lie in the plane of the ring and are conjugated with the aromatic system, whereas in (IIb), they are almost perpendicular to the phenyl ring and are positioned on opposite sides.     

A complex containing both five‐ and six‐coordinate [bis(5‐bromosalicyli­dene)benzene‐1,2‐diimine]chloro­iron(III)

The title compound, aqua­chloro{4,4′‐di­bromo‐2,2′‐[o‐phenylenebis­(nitrilo­methyl­idyne)]­diphenolato‐O,N,N′,O′}iron(III)–chloro{4,4′‐di­bromo‐2,2′‐[o‐phenyl­enebis­(nitrilomethyli‐dyne)]diphenolato‐O,N,N′,O′}iron(III)–di­methyl­form­amide (1/1/1), [FeCl(C₂₀H₁₂Br₂N₂O₂)][FeCl(C₂₀H₁₂Br₂N₂O₂)(H₂O)]·C₃H₇NO, contains one independent five‐coordinate [FeCl(C₂₀H₁₂Br₂N₂O₂)] monomer, one six‐coordinate [FeCl(C₂₀H₁₂Br₂N₂O₂)(H₂O)] monomer and a non‐coordinating di­methyl­form­amide solvent mol­ecule in the asymmetric unit. In the five‐coordinate monomer, the Fe atom shows distorted square‐pyramidal geometry, with the N and O atoms of the ligand at the base and the Cl atom at the apex of the pyramid. In the six‐coordinate monomer, the Fe atom is in a distorted octahedral geometry and coordinated by the donor atoms of the tetrafunctional ligand in the horizontal plane, and the coordination sphere is completed by the O atom of the water mol­ecule and the Cl atom at the axial positions. The title compound contains intermolecular O—H?O hydrogen bonds. Apart from these hydrogen bonds, there are also intermolecular C—H?Cl and C—H?O contacts.     

cyclo(‐Cha–Oxz–d‐Val–Thz–Ile–Oxz–d‐Val–Thz‐) N,N‐di­methyl­acetamide dihydrate: a square form of cyclo­hexyl­alanine‐incorporated ascidiacycl­amide having the strongest cytotoxicity

The title compound, 1‐cyclo­hexyl­methyl‐1‐de(1‐methyl­propyl)­asci­dia­cycl­amide N,N‐di­methyl­acet­amide di­hy­drate, C₃₉H₅₆N₈O₆S₂·C₄H₉NO·2H₂O, a cyclo­hexyl­alanine‐incorporated ascidiacycl­amide analogue ([Cha]ASC), shows a square form similar to natural ASC. On the other hand, CD (circular dichroism) spectra showed [Cha]ASC to have a folded structure in solution, making it the second known analogue to show a discrepancy between its crystal and solution structures. Moreover, the cytotoxicity of [Cha]ASC (ED₅₀ = 5.6 µg ml⁻¹) was approximately two times stronger than that of natural ASC or a related phenyl­alanine‐incorporated analogue, viz. cyclo(‐Phe–Oxz–d ‐Val–Thz–Ile–Oxz–d ‐Val–Thz‐) ([Phe]ASC), and was confirmed to be associated with the square form. However, [Phe]ASC was previously shown to be folded in the crystal structure, which suggests that the difference between the aromatic and aliphatic rings affects the molecular folding of the ASC mol­ecule.     

(5,11,17,23‐Tetra‐tert‐butyl‐26,28‐di­hydroxy­calix­[4]­arene‐25,27‐dioxy)­di­acetic acid N,N‐di­methyl­form­amide trisolvate

The title compound, C₄₈H₆₀O₈·3C₃H₇NO, is a derivative of calix­[4]­arene in the cone conformation, modified with distal carboxylic acid functional groups at the lower rim. A clathrate di­methyl­form­amide (DMF) mol­ecule is located within the calix­[4]­arene cone, and two DMF solvate mol­ecules participate in hydrogen bonding with the carboxylic acid groups. Intramolecular hydrogen bonds are also formed between the OH groups and the adjacent ether groups in the partially substituted calix­[4]­arene.     

Piv‐Proψ[CH2–NH–O]Gly–NHiPr

The pseudodipeptide, (S)‐N‐iso­propyl {[N‐(pivaloyl)­pyrrol­idin‐2‐yl]­methyl­amino­oxy}acet­amide, C₁₅H₂₉N₃O₃, adopts a global extended conformation with the hydroxy­l­amine group in the g⁺/g^? structure. The C‐terminal amide NH interacts intramolecularly with the hydroxy­lamine O atom. Both NH bonds of each mol­ecule are hydrogen bonded to the C‐­terminal amide carbonyl of a neighbouring mol­ecule.     

Hydro­gen‐bonded adducts of ferrocene‐1,1′‐diyl­bis­(di­phenyl­methanol): monomeric and polymeric adducts with 1,2‐bis(4‐pyridyl)­ethene and 1,6‐di­amino­hexane

In the adduct ferrocene‐1,1′‐diyl­bis­(di­phenyl­methanol)–1,2‐bis(4‐pyridyl)­ethene (1/1), [Fe(C₁₈H₁₅O)₂]·C₁₂H₁₀N₂, there is an intramolecular O—H?O hydrogen bond in the ferro­cene­diol component and a single O—H?N hydrogen bond linking the diol to the di­amine, which is disordered over two sets of sites, so forming a finite monomeric adduct. In the adduct ferrocene‐1,1′‐diyl­bis­(di­phenyl­methanol)–1,6‐di­amino­hexane (2/1), 2[Fe(C₁₈H₁₅O)₂]·C₆H₁₆N₂, the amine lies across a centre of inversion in space group P. There is an intramolecular O—H?O hydrogen bond in the ferrocenediol, and the molecular components are linked by O—H?N and N—H?O hydrogen bonds, one of each type, into a C(13)[R(12)] chain of rings.     

Four cytotoxic N4‐substituted thiosemicarbazones derived from 2‐hydroxynaphthalene‐1‐carboxaldehyde

The X‐ray crystal structures are reported of four novel and potentially O,N,S‐tridentate donor ligands that demonstrate antitumour activity. These ligands are 1‐[(4‐methyl­thio­semicarbazono)methyl]‐2‐naphthol, C₁₃H₁₃N₃OS, (III), 1‐[(4‐ethylthio­semicarbazono)­methyl]‐2‐naphthol, C₁₄H₁₅N₃OS, (IV), 1‐[(4‐phenyl­thio­semicarbazono)­methyl]‐2‐naphthol, C₁₈H₁₅N₃OS, (V), and 1‐[(4,4‐di­methyl­thio­semicarbazono)­methyl]‐2‐naphthol di­methyl sulfoxide solvate, C₁₄H₁₅N₃OS·C₂H₆OS, (VI). These chelators are N4‐substituted thio­semicarbazones, each based on the same parent aldehyde, namely 2‐­zhydroxynaphthalene‐1‐carboxaldehyde isonicotinoylhydrazone. Conformational variations within this series are discussed in relation to the optimum conformation for metal‐ion binding.     

(6R*,16R*)‐9,14‐Dihydro‐6‐methyl‐6,16‐methano‐6H,16H‐[2,4]benzothiazepino[3,4‐d][1,3,5]benzoxadiazocine hydrobromide dimethylformamide hemisolvate

The title compound, C₁₉H₁₉N₂OS⁺·Br^?·0.5C₃H₇NO, is an oxygen‐bridged phenyl­pyrimidine derivative in which the heterocyclic ring is protonated, the positive charge being dispersed over both of the N atoms. Both mol­ecules in the asymmetric unit exist in an identical conformation, which consists of a central planar portion with the two terminal phenyl rings protruding from the same side of the plane. One of the independent mol­ecules forms a strong hydrogen bond with the bromide anion, while the other is hydrogen bonded to the di­methyl­form­amide solvent mol­ecule.     

Azole. 45.

The three title compounds, namely (Z)‐1‐(4,5‐di­nitro­imidazol‐1‐yl)‐3‐morpholinopropan‐2‐one 2,4‐di­nitro­phenyl­hydrazone, C₁₆H₁₇N₉O₉, (IV), (Z)‐3‐morpholino‐1‐(4‐morpholino‐5‐nitro­imidazol‐1‐yl)propan‐2‐one 2,4‐di­nitro­phenyl­hydrazone, C₂₀H₂₅N₉O₈, (Va), and (E)‐3‐morpholino‐1‐(4‐morpholino‐5‐nitro­imidazol‐1‐yl)propan‐2‐one 2,4‐di­nitro­phenylhydra­zone tetra­hydro­furan solvate, C₂₀H₂₅N₉O₈·C₄H₈O, (Vb), have been prepared and their structures determined. In (IV), the C‐4 nitro group is nearly perpendicular to the imidazole ring and the C‐4—NO₂ bond length is comparable to the value for a normal single Csp²—NO₂ bond. In (IV), (Va) and (Vb), the C‐­5 nitro group deviates insignificantly from the imidazole plane and the C‐5—NO₂ bond length is far shorter in all three compounds than C‐4—NO₂ in (IV). In consequence, the C‐4 nitro group in (IV) is easily replaced by morpholine, while the C‐5 nitro group in (IV), (Va) and (Vb) shows an extraordinary stability on treatment with the amine. The E configuration in (Vb) is stabilized by a three‐centre hydrogen bond.     

[Bis­(di­phenyl­phosphino)­alkane](pentane‐2,4‐di­thionato) complexes of nickel(II)

The structures of a series of four‐coordinate nickel(II) complexes of the form [Ni(sacsac)L] PF₆ (sacsac = pentane‐2,4‐di­thione anion; L = (Ph₂P)₂(CH₂)_n, n = 1,2,3) have beendetermined. These are [bis­(di­phenyl­phosphino)­methane](pentane‐2,4‐di­thionato‐S,S′)­nickel(II) hexa­fluoro­phosphate, [Ni(C₂₅H₂₂P₂)(C₅H₇S₂)]PF₆, [1,2‐bis­(di­phenylphosphino)­ethane](pentane‐2,4‐di­thionato–S,S′)­nickel(II) hexa­fluoro­phosphate, [Ni(C₂₆H₂₄P₂)(C₅H₇S₂)]PF₆, and [1,3‐bis­(di­phenyl­phosphino)­propane](pentane‐2,4‐di­thionato‐S,S′)­nickel(II) hexa­fluoro­phosphate, [Ni(C₂₇H₂₆P₂)(C₅H₇S₂)]PF₆. All have a distorted square‐planar arrangement about Ni with angles around Ni varying with the length of the hydro­carbon chain.     

From α‐carbamoyl‐α‐cyano­oxiranes to 3‐halogenopyruv­amides

The crystal structures of the first stable α‐diol from the α‐halogenopyruv­amide series, 3‐chloro‐2,2‐di­hydroxy‐3‐phenyl­propan­amide, C₉H₁₀­ClNO₃, and three products [3‐(4‐chloro­phenyl)‐2‐cyano‐2,3‐epoxy­propan­amide, C₁₀H₇­ClN₂O₂, 3‐bromo‐2‐cyano‐2‐hydroxy‐3‐p‐tolyl­propan­amide, C₁₁H₁₁Br­N₂O₂, 3‐bromo‐2‐oxo‐3‐p‐tolyl­propan­amide, C₁₀H₁₀­BrNO₂] obtained during the systematic synthesis of α‐halogenopyruv­amides are reported. The crystal structures are dominated by hydrogen bonds involving an amide group. The stability of the geminal diol could be ascribed to hydrogen bonds which involve both hydroxyl groups.     

3,5‐Di­fluoro‐4‐nitro­pyridine N‐oxide and 3,5‐di­amino‐4‐nitro­pyridine N‐oxide monohydrate

The mol­ecule of 3,5‐di­fluoro‐4‐nitro­pyridine N‐oxide, C₅H₂F₂N₂O₃, is twisted around the C—NO₂ bond by 38.5 (1)°, while the 3,5‐di­amino analogue, 3,5‐di­amino‐4‐nitro­pyridine N‐oxide monohydrate, C₅H₆N₄O₃·H₂O, adopts a planar conformation stabilized by intramolecular hydrogen bonds, with a significant redistribution of π electrons.     

1d‐3,4‐Di‐O‐(di­phenyl­methylphos­pho­nio)‐1,2,5,6‐tetra‐O‐methyl‐chiro‐inositol diiodide

The title compound, 3,4,5,6‐tetra­methoxy­cyclo­hexane‐1,2‐diyl­dioxy­bis­(methyl­di­phenyl­phospho­nium) diiodide, C₃₆­H₄₄­O₆­P₂²⁺·­2I^?, was prepared from a New Zealand natural product, d ‐chiro‐inositol, in order to develop new catalytic metal complexes. The inositol ring retains its usual chair conformation with only minor perturbations caused by the bound di­phenyl­methyl­phosphines. Crystal‐packing forces are provided by C—H?I cation–anion interactions.     

Charge‐transfer complexes of N‐methyl‐and N‐ethyl­carbazole with 3,5‐di­nitro­benzo­nitrile

In the two title compounds, N‐methyl­carba­zole–3,5‐di­nitro­benzo­nitrile (1/1), C₁₃H₁₁N·C₇H₃N₃O₄, (I), and N‐ethyl­carba­zole–3,5‐di­nitro­benzo­nitrile (1/1), C₁₄H₁₃N·C₇H₃N₃O₄, (II), the donor and acceptor mol­ecules are stacked alternately to form one‐dimensional columns. In (I), the N‐methyl group of the donor is nearly eclipsed with respect to one of the nitro groups of the neighboring acceptor in a column, whereas the N‐ethyl group is anti with respect to the cyano group of the neighboring acceptor in (II).     

[N,N‐Bis(2‐hydroxy­ethyl)­di­thio­car­bamato‐S]­bis­(tri­phenyl­phosphine‐P)­copper(I) tri­phenyl­phosphine solvate

In the title compound, [Cu(C₅H₁₀NO₂S₂)(C₁₈H₁₅P)₂]·C₁₈H₁₅P, the Cu atom is in a distorted tetrahedral coordination, with two tri­phenyl­phosphine P atoms and two S atoms from an N,N‐bis(2‐hydroxy­ethyl)­di­thio­carbamate ligand occupying the vertices. The crystal structure is characterized by alternate layers of complex and tri­phenyl­phosphine mol­ecules.     

[2,6‐Bis(1H‐benzimidazol‐2‐yl‐κN3)­pyridine‐κN](di­methyl­form­amide‐κO)­(thio­sulfato‐κ2O,S)­nickel(II) mono­hydrate

The structure of the title compound, [Ni(ths)(bbip)(dmf)]·­H₂O [ths is thio­sulfate, S₂O₃; bbip is 2,6‐bis(1H‐benz­imidazol‐2‐yl)­pyridine, C₂₁H₁₃N₅; and dmf is di­methyl­form­amide, C₃H₇NO], is monomeric, with the nickel ion octahe­drally surrounded by an N,N′,N′′‐tridentate bbip mol­ecule, an S,O‐bidentate ths mol­ecule and an O‐monodentate dmf mol­ecule. The H atoms of the hydration water mol­ecule and the amino groups of bbip are involved in hydrogen bonding and determine a spatial organization of broad layers parallel to (001), which are connected by weak interactions.